Mikael Dolsten

Mikael Dolsten

Director/Board Member at ROCKET PHARMACEUTICALS, INC.

Net worth: 800 273 $ as of 31/05/2026

68 year
Health Technology
Commercial Services
Consumer Services

Profile

Mikael Dolsten holds the position of Chief Scientific Officer & Research President at Pfizer Inc. Dr. Dolsten is also on the board of New York Academy of Sciences, Karyopharm Therapeutics, Inc. and PhRMA Foundation and Member of Royal Swedish Academy of Engineering Sciences and Member of Government-University-Industry Research Roundtable. In the past he occupied the position of Principal at OrbiMed Advisors LLC and Partner at OrbiMed Advisors Private Equity (a subsidiary of OrbiMed Advisors LLC), President for Wyeth Research, EVP, Global Head-Pharma Research & Discovery at Boehringer Ingelheim Pharmaceuticals, Inc., Senior Vice President for Wyeth Corp. and Member-Benefits, Law & Regulatory Committee at Wyeth Pharmaceuticals LLC. Dr. Dolsten received a doctorate from the University of Lund.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
29/05/2026 5,548 ( 0% ) 751 920 $ 31/05/2026
24/03/2026 15,750 ( 0.01% ) 48 353 $ 31/05/2026

Mikael Dolsten active positions

CompaniesPositionStart
AGILENT TECHNOLOGIES, INC. Director/Board Member 21/09/2021
ROCKET PHARMACEUTICALS, INC. Director/Board Member 09/09/2024
Corporate Officer/Principal -
Chairman -
Corporate Officer/Principal -
Director/Board Member -
Corporate Officer/Principal -
Director/Board Member 25/05/2011

Former positions of Mikael Dolsten

CompaniesPositionEnd
APELLIS PHARMACEUTICALS, INC. Director/Board Member 14/05/2026
░░░░░░ ░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
See the detail of Mikael Dolsten's experience

Training of Mikael Dolsten

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

73

1st degree connections

23

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies23

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Finance

Commercial Services

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Technology Services

  1. Stock Market
  2. Insiders
  3. Mikael Dolsten
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!